CJC-1295: What the Peptide Is and What the Research Shows
A GHRH analogue with unusual pharmacokinetics — what the DAC modification does, what the clinical data shows for GH and IGF-1, and which claims remain unproven.
Read article →Free delivery on orders over €70
CJC-1295 No DAC
Short-acting GHRH analogue studied in pulsatile GH-release research.
Purity
≥99% (HPLC)

Short-acting GHRH analogue studied in pulsatile GH-release research.
Price
Size
Quantity
In stock· dispatched in 1–2 working days
For laboratory and research use only. Not for human or veterinary use.
Add to orderBacteriostatic Water · 3 mL€8.00CJC-1295 No DAC (Modified GRF 1-29) is a growth-hormone-releasing hormone (GHRH) analogue without the drug affinity complex, giving it a short half-life. It is used in research examining pulsatile growth-hormone release and GHRH receptor binding in in-vitro models.
Recommended storage for this compound:
Handling guidance for laboratory use only. Not instructions for human or veterinary use.
Every batch is tested by an independent third-party laboratory. Below is the full report for this size — HPLC purity results and the chromatogram.
≥99%
Purity(HPLC)